Examkin

Question

Difficulty: MediumImmunologic and Inflammatory Processes

A 55-year-old man presents to the transplant clinic with a 3-day history of fatigue, dark urine, and low-grade fever. He underwent an orthotopic liver transplant 8 weeks ago for alcohol-associated cirrhosis. His current immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. His temperature is 38.1°C (100.6°F), blood pressure is 130/80 mmHg, and heart rate is 90/min. Physical examination reveals scleral icterus and mild right upper quadrant tenderness. Laboratory tests show significantly elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and total bilirubin compared to his baseline from two weeks ago. Tacrolimus trough levels are within the target therapeutic range. The physician suspects acute cellular rejection. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for evaluating and managing this patient's presentation.

  1. 1Perform hepatic Doppler ultrasonography
  2. 2Obtain a percutaneous liver biopsy
  3. 3Administer high-dose intravenous methylprednisolone
  4. 4Administer anti-thymocyte globulin

Answer

The correct sequence for managing suspected acute cellular rejection in a liver transplant recipient is to first perform hepatic Doppler ultrasonography, followed by a percutaneous liver biopsy, then administration of high-dose intravenous methylprednisolone, and finally administration of anti-thymocyte globulin if refractory.
In evaluating acute graft dysfunction after a liver transplant, the initial step must rule out vascular and biliary complications using hepatic Doppler ultrasonography. Once these mechanical issues are excluded, a liver biopsy is necessary to definitively diagnose acute cellular rejection (characterized histologically by portal inflammation, bile duct injury, and endotheliitis) and to rule out opportunistic infections (such as cytomegalovirus) or drug toxicity. After acute cellular rejection is histologically confirmed, the standard first-line treatment is high-dose intravenous corticosteroids. Finally, for the subset of patients who do not respond to initial corticosteroid therapy (steroid-refractory rejection), therapy is escalated to T-cell depleting agents such as anti-thymocyte globulin.

Step-by-Step Solution

1
Rule out structural and vascular complications
Hepatic Doppler ultrasound evaluates the graft vasculature and biliary trees.
Hepatic artery thrombosis or biliary leaks can rapidly lead to graft loss and require immediate surgical or endoscopic intervention rather than immunosuppression.
2
Confirm the diagnosis histologically
Percutaneous liver biopsy differentiates rejection from infection.
Empiric treatment with high-dose steroids without a biopsy can be dangerous if the true cause of graft dysfunction is an opportunistic infection (e.g., cytomegalovirus hepatitis) or recurrent disease.
3
Initiate first-line anti-rejection therapy
Intravenous methylprednisolone pulse therapy is administered.
Corticosteroids blunt the immune inflammatory cascade and are highly effective for most episodes of acute cellular rejection.
4
Escalate to second-line therapy if necessary
Anti-thymocyte globulin is given if the patient does not clinically or biochemically improve.
This agent is used for steroid-refractory rejection to aggressively deplete the T-lymphocytes that are mediating the graft destruction.

Key Concept

Sequential management of suspected acute cellular rejection in a liver transplant recipient
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic